Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 173

Results For "EDS"

1748 News Found

Zydus new initiative to safeguard patients against counterfeit drugs
News | May 29, 2021

Zydus new initiative to safeguard patients against counterfeit drugs

The patients can check to see if the product purchased by them is genuine or not by scratching the surface and verifying the code through the app or the website


Lupin receives US $50 mn on achieving cancer milestone
News | May 28, 2021

Lupin receives US $50 mn on achieving cancer milestone

MEK inhibitor compound (LNP3794) developed as part of its oncology pipeline had previously shown pre-clinical activity as a single agent as well as in combination


Dishman Carbogen Amcis announces successful results for treatment for vitamin D deficiency
News | May 21, 2021

Dishman Carbogen Amcis announces successful results for treatment for vitamin D deficiency

Researchers observed that a form of vitamin D, known as 25-hydroxyvitamin D3 (Calcifediol), was absorbed faster and better than the same dose of vitamin D.


Cadila Healthcare divests animal health business: ICICI Securities
News | May 16, 2021

Cadila Healthcare divests animal health business: ICICI Securities

The company plans to aggressively invest in longer gestation period projects like innovation, biosimilars, vaccines, etc.


Additional Tocilizumab allocated to states: Gowda
News | May 12, 2021

Additional Tocilizumab allocated to states: Gowda

The additional allocation of Tocilizumab will ensure sufficient availability for COVID-19 patients and augment the government’s efforts to fight the pandemic


Brinton triples production of COVID-19 drug Favipiravir
News | May 12, 2021

Brinton triples production of COVID-19 drug Favipiravir

Favipiravir is close to Remdesivir, Remdesivir is used to treat moderate to severe cases while Favipiravir is used to treat mild to moderate cases


Lonza announces expansion plans for mammalian manufacturing facilities
News | May 07, 2021

Lonza announces expansion plans for mammalian manufacturing facilities

The facility is expected to be completed in 2024


Reliance produces 1000 MTPD medical grade liquid oxygen
News | May 01, 2021

Reliance produces 1000 MTPD medical grade liquid oxygen

This oxygen is being provided free-of-cost to several state governments across the country to bring immediate relief to over 1 lakh patients on a daily basis


Vaishali Pharma bags order worth US $270,000 from Afghanistan
News | April 26, 2021

Vaishali Pharma bags order worth US $270,000 from Afghanistan

This achievement enables the company to strengthen its presence in the high growth market of South Asian countries


Lonza and Immunitas announce manufacturing agreement
News | April 18, 2021

Lonza and Immunitas announce manufacturing agreement

Lonza's Ibex Design end-to-end offering will cover the development stages of IMT-009 from development candidates through early clinical studies